Search Videos and More
News
Temple Lung Center | Enrolling Clinical Trials
The Temple Lung Center conducts one of the most comprehensive lung disease clinical trials programs in the country. Our advancements in basic, translational and clinical research are changing lung disease treatment. By pioneering effective therapies, we bring hope to patients with serious and debilitating lung diseases.
News
Temple Lung Center Performs First Procedure in AIRFLOW-4 Clinical Trial for COPD
The Temple Lung Center has performed the first procedure in the AIRFLOW-4 clinical trial, evaluating the investigational dNerva® Lung Denervation System — a novel, non-implant, bronchoscopic therapy designed to target the underlying neural drivers of COPD symptoms. Patient enrollment is currently underway.
News
FAQ: Building and Scaling a High-Performance Lung Transplant Program
Lung transplantation remains one of the most complex, resource-intensive interventions in pulmonary medicine, requiring precise coordination across disciplines, rapid evaluation pathways, and long-term patient management strategies.
News
Temple Lung Center at ATS 2026: Conference Recap
The American Thoracic Society's 2026 International Conference brought together leading voices in pulmonary, critical care, and sleep medicine — and Temple Health was well represented.
News
Temple Lung Center Joins National Bronchiectasis and NTM Care Center Network
Temple Lung Center is proud to announce its official designation as a member of the Bronchiectasis and NTM Care Center Network, a national collaborative dedicated to advancing research, improving standards of care, and expanding access to specialized treatment for patients living with bronchiectasis and nontuberculous mycobacterial (NTM) lung disease.
News
Temple Lung Center: Advances in Lung Care and Research in 2025
Pulmonary care is evolving rapidly, from earlier detection strategies to new minimally invasive therapies and expanding access to clinical trials.
News
COPD Clinical Trials at Temple Lung Center
Chronic obstructive pulmonary disease (COPD) remains a major cause of morbidity, and many patients continue to experience symptoms despite optimal therapy. As one of the world’s largest and most experienced COPD research programs, the Temple Lung Center offers access to clinical trials evaluating new pharmacologic, device-based, and comprehensive treatment approaches.
News
Temple Sets New National Record in Lung Transplant
The Temple Lung Center is one of the most active and experienced lung transplant programs in the world - and a national destination for complex, high-risk patients.
News
2026 GOLD Report: A Landmark Revision Shaping the Future of COPD Management
The Temple Lung Center continues to play a defining role in advancing the global standard of care for patients with chronic obstructive pulmonary disease (COPD). As a contributor to the international dialogue on evidence-based best practices, the Temple Lung Center not only helped support the development of the 2026 Global Initiative for Chronic Obstructive Lung Disease (GOLD) Report, but also played a role in shaping discussions at the 2025 GOLD Conference—where global experts convened to preview evolving evidence and clinical trends, as well as review updates to the standard of care for COPD patients.
News
Temple Lung Center Performs First U.S. BREATHE-3 Procedure for Severe Emphysema
The Phase-3 trial of Apreo Health’s bronchoscopic airway scaffold for severe emphysema and hyperinflation is now enrolling at the Temple Lung Center.
Course
AI-Powered LDCT: Temple Establishes New Paradigm for Lung Disease Detection
Pulmonologists are at the forefront of detecting and managing lung disease - and now, artificial intelligence (AI) is redefining what’s possible in early detection and workflow efficiency. The Temple Lung Center has become the first pulmonary program in the nation to integrate AI into routine lung screening, using AI software as a core diagnostic tool that supports early detection, multidisciplinary review, and streamlined patient care pathways.
News
Temple Lung Center: Advancing Research in ILD
Interstitial lung diseases (ILD) significantly impact patient morbidity and mortality. As an ILD Center of Excellence, the Temple Lung Center has established comprehensive programs for the evaluation and management of patients with a wide range of ILDs. This includes extensive clinical research and lung transplantation expertise.